242
Views
12
CrossRef citations to date
0
Altmetric
Rheumatology

Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 677-686 | Received 23 Sep 2019, Accepted 22 Jan 2020, Published online: 11 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Daniel Resende Faleiros, Everton Nunes da Silva, Andreia C Santos, Brian B. Godman, Ramon Goncalves Pereira & Augusto A Guerra Junior. (2022) Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisions. Expert Review of Pharmacoeconomics & Outcomes Research 22:6, pages 927-939.
Read now
Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro Dos Santos, Alessandra Maciel Almeida, Juliana Alvares-Teodoro & Francisco De Assis Acurcio. (2022) Economic evaluation of adalimumab versus etanercept for psoriatic arthritis in a Brazilian real-world model. Expert Review of Pharmacoeconomics & Outcomes Research 22:3, pages 473-479.
Read now

Articles from other publishers (10)

Johan Dalén, Axel Svedbom, Emma Hernlund, Tor Olofsson & Christopher M. Black. (2023) Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication. Advances in Therapy 40:10, pages 4657-4674.
Crossref
Haibo Li, Jingjing Liu & Xueping Ji. (2023) Interferon-alpha 1 expression indicates the disease activity and response of patients with ankylosing spondylitis to anti-TNF-α treatment. Modern Rheumatology.
Crossref
Yulan Hu, Bo Lou, Zhonghua Jiang & Chunchu Yu. (2023) Predictive Values of Blood Type I and Type II Interferon Production for Disease Activity and Clinical Response to TNF-<i>α</i> Blocking Therapy in Patients with Ankylosing Spondylitis. The Tohoku Journal of Experimental Medicine 260:3, pages 263-271.
Crossref
Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, Adriana Maria Kakehasi, Alessandra Maciel Almeida, Pedro Ricardo Kömel Pimenta, Juliana Alvares-Teodoro & Francisco de Assis Acurcio. (2022) First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study. Sao Paulo Medical Journal 140:6, pages 787-797.
Crossref
Sang‐Hoon Lee, Yong‐Gil Kim, Seung‐Geun Lee, Soo Hyun Lee, Young‐Joo Kim, Ja‐Young Jeon, Joo‐Young Jo, Hyun‐Jeong Yoo, Juneyoung Lee & Tae‐Hwan Kim. (2022) Treatment pattern, satisfaction, and productivity loss of patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors in Korea: A multicenter cross‐sectional observational study. International Journal of Rheumatic Diseases 25:5, pages 523-531.
Crossref
Ludmila Peres Gargano, Isabella de Figueiredo Zuppo, Mariana Martins Gonzaga do Nascimento, Valéria Maria Augusto, Brian Godman, Juliana de Oliveira Costa, Francisco Assis Acúrcio, Juliana Álvares-Teodoro & Augusto Afonso GuerraJr.Jr.. (2022) Survival Analysis of COPD Patients in a 13-Year Nationwide Cohort Study of the Brazilian National Health System. Frontiers in Big Data 4.
Crossref
Selda HAKBİLEN, Dilek TEZCAN & Sema YİLMAZ. (2022) Kaposi's sarcoma in an Ankylosing Spondylitis patient treated with Anti-Tumor Necrosis Factor-Alpha (Anti-TNF-α) Therapy. Turkish Journal of Internal Medicine 4:1, pages 49-53.
Crossref
Luiza Ohasi de Figueiredo, Augusto Afonso Guerra Júnior, Francisco de Assis Acurcio, Alessandra Maciel Almeida, Mariângela Leal Cherchiglia, Alberto Julius Alves Wainstein, Luiz Claudio Santos Thuler & Angélica Nogueira-Rodrigues. (2021) A demographic and clinical panorama of a sixteen-year cohort of soft tissue sarcoma patients in Brazil. Scientific Reports 11:1.
Crossref
Pedro Ricardo Kömel Pimenta, Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, Adriana Maria Kakehasi, Francisco de Assis Acurcio & Juliana Alvares-Teodoro. (2021) Effectiveness and safety of anti-TNF therapy for ankylosing spondylitis: a real-world study. Journal of Comparative Effectiveness Research 10:6, pages 509-517.
Crossref
Chia-Ling Yu, Chung-Han Yang & Ching-Chi Chi. (2020) Drug Survival of Biologics in Treating Ankylosing Spondylitis: A Systematic Review and Meta-analysis of Real-World Evidence. BioDrugs 34:5, pages 669-679.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.